150 related articles for article (PubMed ID: 36922022)
1. Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study.
Milgrom SA; Kim J; Pei Q; Lee I; Hoppe BS; Wu Y; Hodgson D; Kessel S; McCarten KM; Roberts K; Lo AC; Cole PD; Kelly KM; Cho SY
Br J Haematol; 2023 Jun; 201(6):1192-1199. PubMed ID: 36922022
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031.
Milgrom SA; Kim J; Chirindel A; Kim J; Pei Q; Chen L; Buxton A; Kessel S; Leal J; McCarten KM; Hoppe BS; Wolden SL; Schwartz CL; Friedman DL; Kelly KM; Cho SY
Pediatr Blood Cancer; 2021 Sep; 68(9):e29212. PubMed ID: 34245210
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of metabolic tumour volume and total lesion glycolysis for dogs staged for appendicular osteosarcoma with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Griffin LR; Brody A; Lee BI
Vet Comp Oncol; 2022 Mar; 20(1):59-68. PubMed ID: 33988286
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of baseline and interim [
Yadgarov MY; Dunaykin MM; Shestopalov GI; Kailash C; Kireeva ED; Myakova NV; Likar YN
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1955-1964. PubMed ID: 38351389
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative analysis of interim
Ribeiro T; Marques A; Ferreira G; Castro C; Tavares M; Espírito-Santo A; Moreira C; Mariz J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):281-286. PubMed ID: 34425968
[TBL] [Abstract][Full Text] [Related]
7.
Infante JR; Cabrera J; Rayo JI; Cruz C; Serrano J; Moreno M; Martínez A; Jiménez P; Cobo A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):353-359. PubMed ID: 32605894
[TBL] [Abstract][Full Text] [Related]
8. Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphoma.
Rogasch JMM; Hundsdoerfer P; Hofheinz F; Wedel F; Schatka I; Amthauer H; Furth C
BMC Cancer; 2018 May; 18(1):521. PubMed ID: 29724189
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial.
van Heek L; Stuka C; Kaul H; Müller H; Mettler J; Hitz F; Baues C; Fuchs M; Borchmann P; Engert A; Dietlein M; Voltin CA; Kobe C
BMC Cancer; 2022 Jun; 22(1):672. PubMed ID: 35717166
[TBL] [Abstract][Full Text] [Related]
10. Prostate incidentaloma on 18F-fluorodeoxyglucose positron emission tomography: Diagnostic value of volumetric positron emission tomography parameters.
Şahin Ö; Kaya B; Aydın Z; Şen AE; İyisoy MS; Aydın A
Nuklearmedizin; 2021 Dec; 60(6):394-402. PubMed ID: 34243190
[TBL] [Abstract][Full Text] [Related]
11. Metabolic parameters of [
Markus M; Sartor H; Bjurberg M; Trägårdh E
Acta Oncol; 2023 Feb; 62(2):180-188. PubMed ID: 36815676
[TBL] [Abstract][Full Text] [Related]
12. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Friedman DL; Chen L; Wolden S; Buxton A; McCarten K; FitzGerald TJ; Kessel S; De Alarcon PA; Chen AR; Kobrinsky N; Ehrlich P; Hutchison RE; Constine LS; Schwartz CL
J Clin Oncol; 2014 Nov; 32(32):3651-8. PubMed ID: 25311218
[TBL] [Abstract][Full Text] [Related]
13. Potential Added Value of
Chen S; Wang G; Wu L; Chen D; Fang K; Liu W; Xu B; Zhai YQ; Li M
BMC Gastroenterol; 2024 Jan; 24(1):37. PubMed ID: 38233765
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Metabolic and Volumetric Parameters of FDG PET in Pediatric Osteosarcoma: A Hypothesis-generating Study.
Im HJ; Zhang Y; Wu H; Wu J; Daw NC; Navid F; Shulkin BL; Cho SY
Radiology; 2018 Apr; 287(1):303-312. PubMed ID: 29357275
[TBL] [Abstract][Full Text] [Related]
16. Comparative characteristics of quantitative indexes for 18F-FDG uptake and metabolic volume in sequentially obtained PET/MRI and PET/CT.
Lee SJ; Paeng JC; Goo JM; Lee JM; Cheon GJ; Lee DS; Chung JK; Kang KW
Nucl Med Commun; 2017 Apr; 38(4):333-339. PubMed ID: 28252525
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
Wu LL; Liang JH; Wang L; Xu W; Ding CY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
[No Abstract] [Full Text] [Related]
19. Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.
Song MK; Chung JS; Lee JJ; Jeong SY; Lee SM; Hong JS; Chong A; Moon JH; Kim JH; Lee SM; Kim SJ; Shin HJ
Cancer Sci; 2013 Dec; 104(12):1656-61. PubMed ID: 24033666
[TBL] [Abstract][Full Text] [Related]
20. Validation of a Multifocal Segmentation Method for Measuring Metabolic Tumor Volume in Hodgkin Lymphoma.
Camacho MR; Etchebehere E; Tardelli N; Delamain MT; Vercosa AFA; Takahashi MES; Brunetto SQ; Metze IGHL; Souza CA; Cerci JJ; Ramos CD
J Nucl Med Technol; 2020 Mar; 48(1):30-35. PubMed ID: 31604902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
